Go Back More Articles
Partially Hydrogenated Oils Serious Health Effects
Products
Catalog
After closely scrutinizing data from scientific
studies and reviews, many European countries have
either banned hydrogenated and partially
hydrogenated oils altogether or have instituted
future dates for elimination of their use in foods.
These government actions concerning the trans fatty
acids (hydrogenated and partially hydrogenated oils)
is directly related to studies that link trans fatty
acid (hydrogenated and partially hydrogenated oil)
consumption from processed foods to the development
of diabetes, cancer and cardiovascular disease.Hydrogenation of oils, with removal of essential
fatty acids, is used in the food industry for the
sole purpose of prolonging the shelf life of
processed foods (to maximize profits). Read the
following documents to inform yourself of the
potential health consequences of trans fats used by
the food industry.
Click here for list of foods that may contain
hydrogenated and partially hydrogenated oils.
The New England Journal of Medicine, June 24,
1999 Vol. 340, No. 25
Trans Fatty Acids and Coronary Heart Disease
Trans unsaturated fatty acids are produced
commercially in large quantities by heating
vegetable oils in the presence of metal catalysts
and hydrogen to form shortening and margarine. Trans
fatty acids are so named because the carbon atoms
adjacent to their double bonds are on opposite
sides, resulting in a straight configuration and a
solid state at room temperature. In contrast,
naturally occurring unsaturated fatty acids contain
double bonds as cis isomers, with adjacent carbons
on the same side of the double bond, resulting in a
bent shape and a liquid state at room temperature.
Partial hydrogenation, the process used to create
trans fatty acids, is primarily used to produce
solid fats. However, it also removes essential
polyunsaturated fatty acids, such as linolenic acid
(omega 3) and linoleic acid (omega 6), because they
tend to oxidize, causing the fat to become rancid
with prolonged storage or when exposed to the high
temperatures used for commercial deep-fat frying.
Trans fatty acids are also produced in the rumen of
cattle, resulting in low levels of these isomers in
dairy and beef fat.
Production of partially hydrogenated fats began
early in the 20th century and increased steadily
until about the 1960s, as processed vegetable fats
displaced animal fats in the diets of most people in
industrialized countries. The initial motivation was
lower cost, but health benefits were later
purported. Levels of trans fatty acids in margarines
have declined as softer margarines have become
popular. The average per capita consumption of trans
fatty acids from partially hydrogenated oils has
remained at about 2 percent of calories since the
1960s, because of the increased use of these fats in
commercially baked products and fast foods.
By the early 1990s it became apparent that the
consumption of trans fatty acids (hydrogenated and
partially hydrogenated oils) had uniquely adverse
effects on blood lipid levels in metabolic studies
and was associated with an increased risk of
coronary heart disease in epidemiologic
investigations. A 1995 industry-sponsored review
concluded that there was insufficient evidence to
take action and that further research was needed.
Since then many more metabolic and epidemiologic
studies have confirmed the adverse effects of trans
fatty acids, stimulating the Food and Drug
Administration to announce plans to include the
trans-fatty-acid content of foods on product labels.
One important issue is whether to list the amount of
trans fatty acids (hydrogenated and partially
hydrogenated oils) separately or to combine it with
the saturated-fat content.
In this article we shall review the effects of
trans fatty acids (hydrogenated and partially
hydrogenated oils) on blood lipid levels that have
been identified in metabolic studies and the
associated risk of coronary heart disease that has
been identified in epidemiologic studies.
Metabolic Studies
Early metabolic studies generally found that the
cholesterol-raising effect of hydrogenated fat was
less than that of saturated fats. However, the focus
on total cholesterol masked the fact that although
trans fatty acids (hydrogenated and partially
hydrogenated oils) and saturated fatty acids
increase low-density lipoprotein (LDL) cholesterol
levels to a similar degree, trans fatty acids also
lower high-density lipoprotein (HDL) cholesterol
levels. A 1990 study demonstrated that the
replacement of a diet high in oleic acid (10 percent
of the daily energy intake), the primary
monounsaturated fat in diets, with a diet high in
trans fatty acids (hydrogenated and partially
hydrogenated oils) increased LDL cholesterol levels
by 14 mg per deciliter (0.37 mmol per liter) and
decreased HDL cholesterol levels by 7 mg per
deciliter (0.17 mmol per liter). In contrast,
replacement of oleic acid with saturated fatty acids
caused a similar increase in LDL cholesterol levels,
but had no effect on HDL cholesterol levels. As a
result, the ratio of LDL cholesterol to HDL
cholesterol was significantly higher with the trans
fatty acids (hydrogenated and partially hydrogenated
oils) diet (2.58) than with the saturated-fat diet
(2.34) or the oleic-acid diet (2.02). These findings
have been confirmed in many studies, including the
study by Lichtenstein et al. reported in this issue
of the Journal, with the use of various levels and
mixtures of trans fatty acids (hydrogenated and
partially hydrogenated oils) , summarizes the
randomized trials that directly compared the effects
of trans fatty acids with those of isocaloric
amounts of cis fatty acids. When the data are
available, the figure also shows the effects of
saturated fatty acids in the same studies.
Because trans fatty acids (hydrogenated and
partially hydrogenated oils) increase LDL
cholesterol to levels similar to those produced by
saturated fatty acids and also decrease HDL
cholesterol levels, the net effect of trans fatty
acids (hydrogenated and partially hydrogenated oils)
on the ratio of LDL cholesterol to HDL cholesterol
is approximately double that of saturated fatty
acids. The only somewhat discordant result was from
a small Malaysian study, which found a considerably
stronger adverse effect of trans fatty acids; we
have conservatively excluded this result in
estimating the regression line in. We also did not
include the study by Almendingen et al. in because
they did not compare a diet high in trans fatty
acids (hydrogenated and partially hydrogenated oils)
with a diet high in oleic acid or polyunsaturated
fat. Almendingen et al. found that trans fatty acids
from hydrogenated fish oil but not from hydrogenated
soybean oil increased the ratio of LDL cholesterol
to HDL cholesterol more than did butter.
The effect of trans fatty acids (hydrogenated and
partially hydrogenated oils) on the ratio of LDL
cholesterol to HDL cholesterol was significantly
larger than that of saturated fatty acids in each of
the six studies that allowed a direct comparison.
Collectively, these studies provide definitive
evidence that trans fatty acids raise this ratio
more than do saturated fatty acids. As shown by the
best-fit regression line in , an absolute increase
of 2 percent in the intake of trans fatty acids
would raise the ratio of LDL cholesterol to HDL
cholesterol by 0.1 unit. Since a 1-unit increase in
the ratio is associated with a 53 percent increase
in the risk of coronary heart disease, the average
intake of 2 percent of calories from trans fatty
acids in the United States would be predicted to
account for a substantial number of deaths from
coronary heart disease.
Other trials have compared the effects of butter
and margarine on blood lipid levels. Because
margarines are usually higher in cis fatty acids
than butter, the specific effects of trans fatty
acids (hydrogenated and partially hydrogenated oils)
cannot be estimated accurately from these trials. A
meta-analysis of these investigations, however,
showed that butter and stick margarines, which
typically contain 20 to 25 percent trans fatty acids
(hydrogenated and partially hydrogenated oils) ,
have similar effects on the ratio of total
cholesterol to HDL cholesterol, whereas soft
margarines, which are low in trans fatty acids
(hydrogenated and partially hydrogenated oils) ,
lower the ratio. These results confirm the
deleterious effects of trans fatty acids
(hydrogenated and partially hydrogenated oils) on
blood lipid levels and indicate that these may
offset the beneficial effects of polyunsaturated
fat.
Besides increasing the ratio of LDL cholesterol
to HDL cholesterol, trans fatty acids (hydrogenated
and partially hydrogenated oils) increase Lp(a)
lipoprotein levels when they are substituted for
saturated fatty acids. A significant increase in
Lp(a) lipoprotein levels was reported in 9 of 10
trials, with an average increase of 0.5 mg per
deciliter per 2 percent of energy intake from trans
fatty acids. High blood levels of Lp(a) lipoprotein
have been associated in some studies with an
increased risk of coronary heart disease; the effect
of the smaller variations in blood levels of Lp(a)
lipoprotein induced by trans fatty acids
(hydrogenated and partially hydrogenated oils) is
uncertain.
Trans fatty acids (hydrogenated and partially
hydrogenated oils) also raise triglyceride levels
measured while subjects are fasting. Numerous
studies have reported increases in triglyceride
levels ranging from 1.0 to 24 mg per deciliter (0.01
to 0.27 mmol per liter), with an average increase of
3.0 mg per deciliter (0.03 mmol per liter) per 2
percent of energy intake from trans fatty acids
(hydrogenated and partially hydrogenated oils) . The
effect of such an increase on the risk of
cardiovascular disease, though limited, is probably
unfavorable.
Epidemiologic Studies
The strong correlation between the level of intake
of saturated fatty acids and the rates of coronary
heart disease among the 16 populations examined in
the Seven Countries Study is often quoted as
evidence that the consumption of saturated fat
increases the risk of coronary heart disease. A
subsequent biochemical analysis of food composites
representing the average intake of each cohort at
base line not only confirmed that the intake of
saturated fatty acids was strongly correlated with
the risk of death from coronary heart disease
(r=0.88, P<0.001) but also showed that the intake of
trans fatty acids was correlated with the risk of
death from coronary heart disease (r=0.78, P<0.001).
Interpretation of comparisons among populations with
widely different lifestyles is hazardous, but these
data leave room for a potentially substantial effect
of trans fatty acids (hydrogenated and partially
hydrogenated oils) on the risk of coronary heart
disease.
Several case-control or cross-sectional studies
have also been conducted. In a case-control study of
subjects in the Boston area, we found a strong and
significant positive association between the intake
of trans fatty acids (hydrogenated and partially
hydrogenated oils), assessed with the use of dietary
questionnaires, and the risk of acute myocardial
infarction. The relative risk of acute myocardial
infarction for the quintile with the highest intake
of trans fatty acids as compared with the quintile
with the lowest intake was 2.4 (P for trend <0.001);
this association was entirely explained by the
intake of these fats from hydrogenated vegetable
oil. Bolton-Smith et al. performed a cross-sectional
analysis of the association between the intake of
trans fatty acids and the presence of previously
undiagnosed coronary heart disease among
participants in the Scottish Heart Study. The intake
of trans fatty acids was positively correlated with
the ratio of LDL plus very-low-density lipoprotein
cholesterol to HDL cholesterol. The odds ratios for
coronary heart disease in the quintile with the
highest intake as compared with the quintile with
the lowest intake were elevated but not
significantly so (1.26 in women and 1.08 in men).
Studies in which the composition of fatty acids
in tissue or plasma was used as a marker of
trans-fatty-acid intake have yielded conflicting
results. With one exception, however, these studies
have been too small to detect an association
reliably. The results of the only large study, which
included 671 men with acute myocardial infarction
from eight European countries, were inconclusive.
The overall analyses revealed no association between
the intake of trans fatty acids and the risk of
myocardial infarction. However, in contrast to the
centers studied in other countries, the two centers
studied in Spain, where the rates of coronary heart
disease are very low, reported extremely low levels
of trans-fatty-acid intake and little variation
between subjects and thus provided little
information. After the exclusion of these data, the
odds ratios for the third and fourth quartiles of
intake, as compared with the lowest, were 1.53 and
1.44, respectively. The interpretation of the
results of this study has caused controversy, but in
any case they do not provide strong evidence against
the hypothesis that the consumption of trans fatty
acids increases the risk of coronary heart disease.
The strongest epidemiologic evidence relating
dietary factors to the risk of coronary heart
disease has been provided by three large prospective
studies: the Health Professionals Follow-up Study,
the Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study, and the Nurses' Health Study. Those studies
assessed the intake of trans fatty acids using
detailed food-frequency questionnaires whose results
were validated by comparison with the composition of
adipose tissue or food diaries. Each of these
studies reported an adverse effect of trans fatty
acids. The relative risk of coronary heart disease
associated with an absolute increase of 2 percent in
the intake of trans fatty acids was 1.36 (95 percent
confidence interval, 1.03 to 1.81) in the Health
Professionals Follow-up Study, 1.14 (95 percent
confidence interval, 0.96 to 1.35) in the Alpha-Tocopherol
Beta-Carotene Cancer Prevention Study, and 1.93 (95
percent confidence interval, 1.43 to 2.61) in the
Nurses' Health Study. The higher relative risk in
the Nurses' Health Study may have resulted from the
fact that there were four dietary measurements
during the follow-up period, thereby reducing the
degree of error in assessing trans-fatty-acid
consumption. In these three cohorts, the relative
risks were higher than those for saturated-fat
consumption. For example, in the Nurses' Health
Study, replacing 5 percent of energy intake from
saturated fat with unsaturated fat was associated
with a 42 percent decrease in the risk of coronary
heart disease, whereas replacing 2 percent of energy
intake from trans fatty acids with cis fatty acids
was associated with a 53 percent decrease in the
risk.
These studies have been criticized on the grounds
that measurements of the intake of trans fatty acids
were unreliable however, random errors in measuring
the intake would only have led to an underestimation
of the association with the risk of coronary heart
disease. It has also been suggested that the
observed associations resulted from a shift from the
use of butter to the use of margarine among
high-risk subjects. If so, the association between
the intake of trans fatty acids and the risk of
coronary heart disease should have been weaker among
subjects with stable margarine consumption and
stronger during the first few years of follow-up.
However, in the Nurses' Health Study,) the exclusion
of women who changed their diet before the beginning
of the study strengthened the association. Moreover,
consumption of foods high in trans fatty acids such
as cookies, which are hardly perceived as healthy,
was also positively associated with the risk of
coronary heart disease.
Confounding as a result of unmeasured or poorly
measured risk factors is a potential problem in any
observational study, but these associations were
adjusted for many risk factors related to diet and
lifestyle, and no credible confounding factor has
been identified. Adjustment for the intake of
dietary fiber attenuated the relation of
trans-fatty-acid intake to the risk of coronary
heart disease in the Health Professionals Follow-up
Study, but not in the other two studies (and Hu FB:
personal communication). Thus, prospective studies
provide consistent evidence that the consumption of
trans fatty acids increases the risk of coronary
heart disease. The observed relative risks of
coronary heart disease were larger than one might
predict from the effects of trans fatty acids on LDL
and HDL cholesterol levels alone. The increases in
triglyceride and Lp(a) lipoprotein levels account
for only a small increase in risk; therefore, other
mechanisms may be involved.
Conclusions
Metabolic and epidemiologic studies indicate an
adverse effect of trans fatty acids on the risk of
coronary heart disease. Furthermore, on a per-gram
basis, the adverse effect of trans fatty acids
appears to be stronger than that of saturated fatty
acids. When ingredients with no known nutritional
benefit are added to foods, a low threshold for
evidence of harm should be adopted, and it should be
the responsibility of food manufacturers to show
that their products are safe. In Europe, producers
have responded rapidly by developing margarines free
of trans fatty acids that are also low in saturated
fats. These products are also becoming available in
the United States, but heavily hydrogenated stick
margarines still retain a large share of the market.
In the United States, only 25 percent to 37 percent
of the intake of trans fatty acids from hydrogenated
vegetable oil comes from margarines; the remainder
comes from baked goods, fried fast foods, and other
prepared foods. It is more difficult to replace
trans fatty acids with healthier fats in such
products than in margarines, but the switch could be
encouraged by a change in federal regulations.
Current U.S. regulations provide an incentive to
manufacturers to produce foods high in trans fatty
acids because food labels are not required to
include the amount of trans fatty acids. Many
scientists agree that the amount of trans fatty
acids should be stated on food labels. One simple
option is to combine this information with the
saturated-fat content. This approach, however,
ignores the observation that the intake of trans
fatty acids is associated with a higher risk of
coronary heart disease than is the intake of
saturated fatty acids.
Although changes in labeling are important, they
are not enough. Many fast foods contain high levels
of trans fatty acids, are exempt from labeling
regulations, and can even be advertised as
cholesterol-free and cooked in vegetable oil. For
example, the consumption of one doughnut at
breakfast (3.2 g of trans fatty acids) and a large
order of french fries at lunch (6.8 g of trans fatty
acids) adds 10 g of trans fatty acids to one's diet
and represents 5 percent of the total energy intake
on an 1800-calorie diet, and neither product needs
to be labeled.
Five years ago, it became evident that
consumption of trans fatty acids adversely affects
blood lipid levels. Subsequent studies have
confirmed these metabolic findings and strengthened
epidemiologic evidence of an important increase in
the risk of coronary heart disease with the
consumption of trans fatty acids. These data
highlight the need for labeling requirements that
include fast foods. Given the proper incentives, the
food industry could replace a large proportion of
the partially hydrogenated fats used in foods and
food preparation with unhydrogenated oils. Such a
change would substantially reduce the risk of
coronary heart disease at a moderate cost, without
requiring major efforts focused on education and
behavioral modification.
Alberto Ascherio, M.D., Dr.P.H., Meir J. Stampfer,
M.D., Dr.P.H., Walter C. Willett, M.D., Dr.P.H.,
Harvard School of Public Health
Martijn B. Katan, Ph.D., Peter L. Zock, Ph.D.
Wageningen Center for Food Sciences, Netherlands
Editorial Comments:
Has the world become a very tight web of deceit
when it comes to what does and what does not
constitute good nutrition? The question of the
negative health effects associated with hydrogenated
oils has been answered several times, yet the
regulatory bodies of many countries and big food
corporations continue to attempt to discredit the
information presented by leading scientists from all
over the world. What is wrong with this picture?
When things to do make sense, we must question the
motives of those groups that are not making sense in
their arguments (corporations that produce food and
the regulatory bodies that are lobbied by these same
big corporations). We must have accountability. When
man-made chemicals pose risk they must be eliminated
expediently from our food supply. Do you feel safe
knowing that government seems to protect industry at
the expense of citizens? |